Showing results (591-600 of 668) with videos related to

Sort By:
Pageof 67
Journal of Immunology (Baltimore, Md. : 1950)|May 22, 2007
IFN-gamma- and TNF-independent vitamin D-inducible human suppression of mycobacteria: the role of cathelicidin LL-37Adrian R Martineau, Katalin A Wilkinson, Sandra M Newton, et al.
The American Journal of Medicine|June 1, 1975
Meningococcal antigen in diagnosis and treatment of group A meningococcal infectionsH C Whittle, B M Greenwood, N Davidson, et al.
European Journal of Cancer (Oxford, England : 1990)|October 15, 2003
An open randomised trial of second-line endocrine therapy in advanced breast cancer. comparison of the aromatase inhibitors letrozole and anastrozoleC Rose, O Vtoraya, A Pluzanska, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1997
Topotecan versus paclitaxel for the treatment of recurrent epithelial ovarian cancerW ten Bokkel Huinink, M Gore, J Carmichael, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 31, 2006
Liposomal amphotericin B for the treatment of visceral leishmaniasisCaryn Bern, Jill Adler-Moore, Juan Berenguer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 3, 2001
Clinical evidence for topotecan-paclitaxel non--cross-resistance in ovarian cancerM Gore, W ten Bokkel Huinink, J Carmichael, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 1, 1996
Short-course treatment of visceral leishmaniasis with liposomal amphotericin B (AmBisome)R N Davidson, L di Martino, L Gradoni, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 11, 2012
Zoledronic acid (zoledronate) for postmenopausal women with early breast cancer receiving adjuvant letrozole (ZO-FAST study): final 60-month resultsR Coleman, R de Boer, H Eidtmann, et al.
Pageof 67